Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

F. Palandri, G.A. Palumbo, E. Abruzzese, A. Iurlo, N. Polverelli, E. Elli, M. Bonifacio, M. Bergamaschi, B. Martino, M. Tiribelli, G. Benevolo, A. Tieghi, N. Sgherza, A. Isidori, G. Binotto, M. Crugnola, F. Heidel, F. Cavazzini, C. Bosi, G. AuteriD. Cattaneo, R. Foà, R.M. Lemoli, A. Cuneo, M. Krampera, D. Bartoletti, M. Cavo, N. Vianelli, M. Breccia, R. Latagliata

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)418-423
JournalHematological Oncology
Volume37
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • EARLY PMF
  • MYELOFIBROSIS
  • OVERT PMF
  • RUXOLITINIB

Cite this

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. / Palandri, F.; Palumbo, G.A.; Abruzzese, E.; Iurlo, A.; Polverelli, N.; Elli, E.; Bonifacio, M.; Bergamaschi, M.; Martino, B.; Tiribelli, M.; Benevolo, G.; Tieghi, A.; Sgherza, N.; Isidori, A.; Binotto, G.; Crugnola, M.; Heidel, F.; Cavazzini, F.; Bosi, C.; Auteri, G.; Cattaneo, D.; Foà, R.; Lemoli, R.M.; Cuneo, A.; Krampera, M.; Bartoletti, D.; Cavo, M.; Vianelli, N.; Breccia, M.; Latagliata, R.

In: Hematological Oncology, Vol. 37, No. 4, 2019, p. 418-423.

Research output: Contribution to journalArticle

Palandri, F, Palumbo, GA, Abruzzese, E, Iurlo, A, Polverelli, N, Elli, E, Bonifacio, M, Bergamaschi, M, Martino, B, Tiribelli, M, Benevolo, G, Tieghi, A, Sgherza, N, Isidori, A, Binotto, G, Crugnola, M, Heidel, F, Cavazzini, F, Bosi, C, Auteri, G, Cattaneo, D, Foà, R, Lemoli, RM, Cuneo, A, Krampera, M, Bartoletti, D, Cavo, M, Vianelli, N, Breccia, M & Latagliata, R 2019, 'Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib', Hematological Oncology, vol. 37, no. 4, pp. 418-423. https://doi.org/10.1002/hon.2619
Palandri, F. ; Palumbo, G.A. ; Abruzzese, E. ; Iurlo, A. ; Polverelli, N. ; Elli, E. ; Bonifacio, M. ; Bergamaschi, M. ; Martino, B. ; Tiribelli, M. ; Benevolo, G. ; Tieghi, A. ; Sgherza, N. ; Isidori, A. ; Binotto, G. ; Crugnola, M. ; Heidel, F. ; Cavazzini, F. ; Bosi, C. ; Auteri, G. ; Cattaneo, D. ; Foà, R. ; Lemoli, R.M. ; Cuneo, A. ; Krampera, M. ; Bartoletti, D. ; Cavo, M. ; Vianelli, N. ; Breccia, M. ; Latagliata, R. / Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. In: Hematological Oncology. 2019 ; Vol. 37, No. 4. pp. 418-423.
@article{c6ac81aaa88748a5aff3b66225064e6f,
title = "Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib",
keywords = "EARLY PMF, MYELOFIBROSIS, OVERT PMF, RUXOLITINIB",
author = "F. Palandri and G.A. Palumbo and E. Abruzzese and A. Iurlo and N. Polverelli and E. Elli and M. Bonifacio and M. Bergamaschi and B. Martino and M. Tiribelli and G. Benevolo and A. Tieghi and N. Sgherza and A. Isidori and G. Binotto and M. Crugnola and F. Heidel and F. Cavazzini and C. Bosi and G. Auteri and D. Cattaneo and R. Fo{\`a} and R.M. Lemoli and A. Cuneo and M. Krampera and D. Bartoletti and M. Cavo and N. Vianelli and M. Breccia and R. Latagliata",
note = "Export Date: 31 October 2019 CODEN: HAOND Correspondence Address: Palandri, F.; Institute of Hematology “L. and A. Ser{\`a}gnoli”, Sant'Orsola-Malpighi University HospitalItaly; email: francesca.palandri@unibo.it",
year = "2019",
doi = "10.1002/hon.2619",
language = "English",
volume = "37",
pages = "418--423",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "4",

}

TY - JOUR

T1 - Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

AU - Palandri, F.

AU - Palumbo, G.A.

AU - Abruzzese, E.

AU - Iurlo, A.

AU - Polverelli, N.

AU - Elli, E.

AU - Bonifacio, M.

AU - Bergamaschi, M.

AU - Martino, B.

AU - Tiribelli, M.

AU - Benevolo, G.

AU - Tieghi, A.

AU - Sgherza, N.

AU - Isidori, A.

AU - Binotto, G.

AU - Crugnola, M.

AU - Heidel, F.

AU - Cavazzini, F.

AU - Bosi, C.

AU - Auteri, G.

AU - Cattaneo, D.

AU - Foà, R.

AU - Lemoli, R.M.

AU - Cuneo, A.

AU - Krampera, M.

AU - Bartoletti, D.

AU - Cavo, M.

AU - Vianelli, N.

AU - Breccia, M.

AU - Latagliata, R.

N1 - Export Date: 31 October 2019 CODEN: HAOND Correspondence Address: Palandri, F.; Institute of Hematology “L. and A. Seràgnoli”, Sant'Orsola-Malpighi University HospitalItaly; email: francesca.palandri@unibo.it

PY - 2019

Y1 - 2019

KW - EARLY PMF

KW - MYELOFIBROSIS

KW - OVERT PMF

KW - RUXOLITINIB

U2 - 10.1002/hon.2619

DO - 10.1002/hon.2619

M3 - Article

VL - 37

SP - 418

EP - 423

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 4

ER -